METTL3 and metastatic neoplasm: Immunohistochemical analysis of subcutaneous tumors and lung metastatic tumors in mice from the sh-METTL3 and sh-NC groups indicated that silencing METTL3 significantly reduced the expression of the M2 macrophage marker CD163 protein (Fig. 6e).